Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14491-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14491-1-AP, RRID:AB_11232411
- Product name
- RPS7 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated RPS7 antibody (Cat. #14491-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Human hematopoietic stem cell vulnerability to ferroptosis.
Identification of RPS7 as the Biomarker of Ferroptosis in Acute Kidney Injury.
SMYD2 promotes tumorigenesis and metastasis of lung adenocarcinoma through RPS7.
RPS7 promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer.
Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis.
Identifying the functional contribution of the defatty-acylase activity of SIRT6.
Stabilization of SIRT7 deacetylase by viral oncoprotein HBx leads to inhibition of growth restrictive RPS7 gene and facilitates cellular transformation.
Zhao J, Jia Y, Mahmut D, Deik AA, Jeanfavre S, Clish CB, Sankaran VG
Cell 2023 Feb 16;186(4):732-747.e16
Cell 2023 Feb 16;186(4):732-747.e16
Identification of RPS7 as the Biomarker of Ferroptosis in Acute Kidney Injury.
Zhang H, Liu X, Zhou L, Deng Z, Wang Y
BioMed research international 2022;2022:3667339
BioMed research international 2022;2022:3667339
SMYD2 promotes tumorigenesis and metastasis of lung adenocarcinoma through RPS7.
Wu L, Kou F, Ji Z, Li B, Zhang B, Guo Y, Yang L
Cell death & disease 2021 May 2;12(5):439
Cell death & disease 2021 May 2;12(5):439
RPS7 promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer.
Wen Y, An Z, Qiao B, Zhang C, Zhang Z
Urologic oncology 2019 May;37(5):297.e1-297.e7
Urologic oncology 2019 May;37(5):297.e1-297.e7
Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis.
Yan H, Guo W, Li K, Tang M, Zhao X, Lei Y, Nie CL, Yuan Z
Experimental cell research 2018 Oct 1;371(1):50-62
Experimental cell research 2018 Oct 1;371(1):50-62
Identifying the functional contribution of the defatty-acylase activity of SIRT6.
Zhang X, Khan S, Jiang H, Antonyak MA, Chen X, Spiegelman NA, Shrimp JH, Cerione RA, Lin H
Nature chemical biology 2016 Aug;12(8):614-20
Nature chemical biology 2016 Aug;12(8):614-20
Stabilization of SIRT7 deacetylase by viral oncoprotein HBx leads to inhibition of growth restrictive RPS7 gene and facilitates cellular transformation.
Pandey V, Kumar V
Scientific reports 2015 Oct 7;5:14806
Scientific reports 2015 Oct 7;5:14806
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The RPS7 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human RPS7. This antibody recognizes human, mouse, rat antigen. The RPS7 antibody has been validated for the following applications: ELISA, WB analysis.